| Full title: |
Optimising Immunotherapy for Māori with Advanced Non Small Cell Lung Cancer |
| Cancer type: |
Advanced Non Small Cell Lung Cancer |
| Status: |
In set up |
| Brief description: |
Immunotherapy is an effective treatment for patients with advanced lung cancer. The Optimise Study aims to describe the experience of Māori receiving immunotherapy for advanced non-small cell lung cancer (NSCLC) in the NZ public health system, understand the clinical features and patterns of existing biomarkers in our own population and measure the survival of Māori with advanced NSCLC referred to receive first-line immunotherapy to see if we are achieving the expected benefits published in the key evidence behind immunotherapy treatment. |
| Sites: |
Auckland & Whangārei |
| Lead Investigator: |
Dr Laird Cameron |
| Contact: |
Jade Scott (j.scott@auckland.ac.nz) |
| Sponsor: |
University of Auckland |
| Funder: |
Health Research Council |
| Trial Registry reference: |
TBC |
| Ethics number: |
21744 |
| Publications: |
None currently |
